Bicocca Open Archive

Logo unimib boa
PIPERNO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.953
AS - Asia 10.120
EU - Europa 8.129
SA - Sud America 1.474
AF - Africa 229
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 40.931
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.498
SG - Singapore 3.723
CN - Cina 2.343
HK - Hong Kong 1.525
RU - Federazione Russa 1.316
DE - Germania 1.094
SE - Svezia 1.086
BR - Brasile 1.074
VN - Vietnam 1.056
IE - Irlanda 968
IT - Italia 948
UA - Ucraina 860
GB - Regno Unito 477
FR - Francia 423
CA - Canada 340
IN - India 311
FI - Finlandia 276
BD - Bangladesh 178
AT - Austria 154
AR - Argentina 142
KR - Corea 139
TR - Turchia 127
IQ - Iraq 104
NL - Olanda 95
PK - Pakistan 89
ID - Indonesia 83
JP - Giappone 79
ES - Italia 72
BE - Belgio 65
ZA - Sudafrica 65
MX - Messico 64
DK - Danimarca 61
PL - Polonia 61
SA - Arabia Saudita 61
EC - Ecuador 53
CO - Colombia 49
PH - Filippine 48
UZ - Uzbekistan 48
VE - Venezuela 46
PE - Perù 36
BG - Bulgaria 31
MA - Marocco 28
ET - Etiopia 27
CL - Cile 26
KE - Kenya 25
LT - Lituania 25
MY - Malesia 23
PY - Paraguay 22
EG - Egitto 20
NP - Nepal 19
TN - Tunisia 19
CH - Svizzera 17
JO - Giordania 17
AE - Emirati Arabi Uniti 15
AU - Australia 15
IR - Iran 15
RO - Romania 15
DO - Repubblica Dominicana 14
BO - Bolivia 13
OM - Oman 13
CZ - Repubblica Ceca 12
HU - Ungheria 12
KZ - Kazakistan 12
DZ - Algeria 11
TW - Taiwan 10
CR - Costa Rica 9
IL - Israele 9
TH - Thailandia 9
UY - Uruguay 9
AZ - Azerbaigian 8
GR - Grecia 8
PS - Palestinian Territory 8
BH - Bahrain 7
HR - Croazia 7
KG - Kirghizistan 7
PA - Panama 7
RS - Serbia 7
SN - Senegal 7
AM - Armenia 6
EU - Europa 6
JM - Giamaica 6
PT - Portogallo 6
NG - Nigeria 5
NO - Norvegia 5
BA - Bosnia-Erzegovina 4
GE - Georgia 4
LB - Libano 4
MD - Moldavia 4
AL - Albania 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MT - Malta 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SC - Seychelles 3
AO - Angola 2
BJ - Benin 2
Totale 40.879
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.013
Singapore 2.162
Ashburn 1.767
Woodbridge 1.748
Hong Kong 1.490
Fairfield 1.438
Houston 1.346
Chandler 1.026
San Jose 972
Dublin 934
Jacksonville 909
Wilmington 751
Frankfurt am Main 674
Seattle 578
Dearborn 565
Cambridge 514
New York 433
Princeton 361
Santa Clara 352
Beijing 341
Chicago 297
The Dalles 294
Ho Chi Minh City 288
Los Angeles 286
Milan 275
Hanoi 248
Nanjing 236
Dallas 202
Shanghai 189
Hefei 185
Lauterbourg 175
Lawrence 174
Lachine 155
Altamura 134
Vienna 129
Seoul 128
Moscow 113
Buffalo 112
São Paulo 110
Council Bluffs 101
San Diego 93
Nanchang 75
Munich 73
Helsinki 72
Andover 67
Guangzhou 66
Shenyang 65
Orem 61
Toronto 60
Brussels 54
Hebei 54
London 53
Boardman 52
Jinan 49
Changsha 47
Dong Ket 47
Tokyo 47
Jakarta 44
Ottawa 44
Tianjin 43
Rio de Janeiro 42
Da Nang 41
Tashkent 41
Jiaxing 40
Turku 40
Montreal 38
Warsaw 38
Belo Horizonte 37
Rome 37
Falls Church 36
Chennai 35
Dhaka 35
Brooklyn 34
Nuremberg 34
Salt Lake City 34
Zhengzhou 34
Phoenix 32
Baghdad 31
Haiphong 30
Johannesburg 28
Denver 27
Lahore 27
Columbus 26
Addis Ababa 24
Mountain View 24
Norwalk 24
Atlanta 23
Boston 23
Fremont 23
Ningbo 23
Mumbai 22
Hải Dương 21
Paris 21
Philadelphia 21
Plovdiv 21
Quito 21
Stockholm 21
Tampa 21
Amsterdam 20
Brasília 20
Totale 27.541
Salva come PNG Salva come JPEG
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 667
Hepcidin regulation in a mouse model of acute hypoxia 583
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 428
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 400
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 395
Hif1a: A putative modifier of hemochromatosis 376
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 373
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 372
Idiopathic erythrocytosis: a germline disease? 368
Juvenile Hemochromatosis 344
Inherited iron overload disorders 335
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 330
Type 3 hemochromatosis and beta-thalassemia trait 327
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 322
Hepcidin regulation in a mouse model of acute hypoxia 322
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 321
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 321
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 320
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 318
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 309
Unexplained isolated hyperferritinemia without iron overload 306
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 305
Circulating factors are involved in hypoxia-induced hepcidin suppression 304
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 299
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 292
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 291
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 289
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 289
Early impairment of large artery structure and function in Type I diabetes mellitus 289
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 285
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 281
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 281
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 280
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 278
Hepatocellular carcinoma in Gaucher disease: an international case series 275
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 272
Hyperferritinemia and diagnosis of type 1 Gaucher disease 272
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 271
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 270
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 270
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 268
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 268
Ferroportin disease: A novel SLC40A1 mutation 268
Increased serum ferritin is common in men with essential hypertension 266
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 263
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 263
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 261
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 259
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 258
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 257
Ceruloplasmin variants might have different effects in different iron overload disorders 257
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 257
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 255
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 251
Different cortical excitability profiles in hereditary brain iron and copper accumulation 250
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: The causes might be more heterogeneous than in thalassaemia 247
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 246
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 245
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 244
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 244
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 242
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 241
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 241
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 240
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 240
Effects of hypobaric hypoxia at high altitude on humoral regulation of blood pressure and body fluids. results of highcare project 239
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 239
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 236
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 236
Commentary 236
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 236
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 235
Homozygous deletion of HFE: The Sardinian hemochromatosis? 229
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 228
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 228
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 228
Biochemical and genetic defects underlying human congenital hypotransferrinemia 227
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 226
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 225
The iron status of Italian subjects with beta-thalassemia trait 222
Myelodysplastic Syndromes and Iron Chelation Therapy 221
Haemochromatosis in patients with β-thalassaemia trait 220
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 220
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 220
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 218
Natural history of juvenile haemochromatosis 216
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 216
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 214
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 213
Erythrocyte ferritin in thalassemia syndromes 212
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 212
Erythrocyte ferritin in patients on chronic hemodialysis treatment 211
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 211
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 211
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 209
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 206
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 205
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 204
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 202
Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene 199
Totale 27.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021414 0 0 0 0 0 0 0 0 0 0 179 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20255.730 396 675 231 241 565 176 225 288 740 815 496 882
2025/202612.560 1.331 757 1.018 1.460 1.782 795 2.094 665 1.207 1.265 186 0
Totale 41.705